Cadmium effects on superoxide dismutase 1 in human cells revealed by NMR by Polykretis, P. et al.
Contents lists available at ScienceDirect
Redox Biology
journal homepage: www.elsevier.com/locate/redox
Research Paper
Cadmium effects on superoxide dismutase 1 in human cells revealed by
NMR
Panagis Polykretisa, Francesca Cencettib, Chiara Donatib, Enrico Luchinata,b,⁎, Lucia Bancia,c,⁎
aMagnetic Resonance Center - CERM, University of Florence, Via Luigi Sacconi 6, 50019 Sesto Fiorentino, Florence, Italy
bDepartment of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Viale Morgagni 50, 50134 Florence, Italy
c Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy
A R T I C L E I N F O
Keywords:
Cadmium
Superoxide dismutase 1
In-cell NMR
Oxidative stress
Metallothionein
A B S T R A C T
Cadmium is a toxic pollutant that in recent decades has become more widespread in the environment due to
anthropogenic activities, significantly increasing the risk of exposure. Concurrently, a continually growing body
of research has begun to enumerate the harmful effects that this heavy metal has on human health.
Consequently, additional research is required to better understand the mechanism and effects of cadmium at the
molecular level. The main mechanism of cadmium toxicity is based on the indirect induction of severe oxidative
stress, through several processes that unbalance the anti-oxidant cellular defence system, including the dis-
placement of metals such as zinc from its native binding sites. Such mechanism was thought to alter the in vivo
enzymatic activity of SOD1, one of the main antioxidant proteins of many tissues, including the central nervous
system. SOD1 misfolding and aggregation is correlated with cytotoxicity in neurodegenerative diseases such as
amyotrophic lateral sclerosis. We assessed the effect of cadmium on SOD1 folding and maturation pathway
directly in human cells through in-cell NMR. Cadmium does not directly bind intracellular SOD1, instead causes
the formation of its intramolecular disulfide bond in the zinc-bound form. Metallothionein overexpression is
strongly induced by cadmium, reaching NMR-detectable levels. The intracellular availability of zinc modulates
both SOD1 oxidation and metallothionein overexpression, strengthening the notion that zinc-loaded me-
tallothioneins help maintaining the redox balance under cadmium-induced acute stress.
1. Introduction
Cadmium is a potent environmental and food contaminant that is
ranked as the seventh most hazardous substance for human health
when considering both toxicity and exposure frequency [1]. Further-
more, it has been classified as a category 1 carcinogen by the Interna-
tional Agency for Research on Cancer [2]. Cadmium can spread in the
environment due to natural processes like volcanic eruptions and ero-
sion, but during recent decades anthropogenic activities such as agri-
culture and industry have significantly boosted its dispersal in soil and
water [3]. Cadmium compounds are very soluble in water, facilitating
its uptake by plants and consequently human exposure as a food and
tobacco contaminant [4,5]. Cadmium is not a physiological element for
any living organism, and furthermore is a cumulative toxin with an
extremely long estimated half-life (up to 13.6–23.5 years) due to its
very low excretion rate [6]. In mammals, the main accumulation sites
of cadmium are kidneys, liver, lungs, bone, testes and brain, where it
causes severe oxidative stress and other detrimental effects [7,8].
Unlike iron and copper, cadmium is not a Fenton-like metal, conse-
quently it is not involved directly in the production of Reactive Oxygen
Species (ROS). Rather, it increases their intracellular production and
their harmful effects by altering the balance of the cellular anti-oxida-
tive defence system. In fact, cadmium is thought to be responsible for
the replacement of metals from their catalytic sites [9–12]; the deple-
tion of anti-oxidant metabolites, like glutathione, ascorbic acid and
vitamin E; the inhibition of the electron transport chain, resulting in
mitochondrial damage; and the alteration of the enzymatic activity of
anti-oxidant proteins [13–15]. One of the main cellular defence tools
against cadmium are metallothioneins (MTs), a family of highly con-
served, cysteine-rich small proteins with several key functions: toxic
metal and radical scavenging, maintenance of the intracellular zinc
homeostasis, maintenance of the intracellular redox balance and pro-
tection against DNA damage [16–18]. Mammalian MTs have about 60
amino acids, one third of which are cysteines, forming two metal-
thiolate clusters. The protein fold is induced by metal ions (such as
Zn2+, Cd2+ and Cu+), and cluster formation [19]. Human MTs have 11
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functional isoforms divided in 4 subfamilies (MT1-4), which share a
high degree of homology and are differentially expressed depending on
the tissue [20]. The expression of MTs is known to be induced by Cd2+
exposure through a mechanism mediated by the release of intracellular
free Zn2+ [21].
Among the anti-oxidant proteins affected by cadmium intoxication,
literature reports the involvement of cadmium in the alteration of the
enzymatic activity of superoxide dismutase 1 (SOD1) [13]. SOD1 is a
metalloprotein that exerts a fundamental anti-oxidant role catalysing
the dismutation of O2•- to H2O2 and O2 with extremely high reaction
rates [22–24]. SOD1 enzymatic activity is essential for the maintenance
of the physiological cellular conditions and requires correct protein
folding, metal binding and disulfide bond formation. The impairment of
SOD1 maturation has been also related to the onset of severe disease
states, including amyotrophic lateral sclerosis (ALS) [25–29].
In vitro, cadmium has been shown to bind to the zinc and copper
sites of SOD1 [30], which are necessary for the structural stability and
catalytic activity of SOD1, respectively. In vivo, however, opposing ef-
fects have been reported on SOD1 activity in response to cadmium
exposure, and evidence of alteration at the protein level is lacking
[31–33]. Therefore, it is not clear whether/how cadmium affects SOD1
folding and metallation within the cell, i.e. in the presence of the native
SOD1 metal ions and under the control of the cellular metal and redox
homeostasis.
Given these contrasting premises, we sought to evaluate the effects
of cadmium treatment on the maturation of SOD1 in human cells by in-
cell NMR, to determine whether cadmium binds to the zinc and/or
copper sites or it affects intracellular SOD1 maturation by other me-
chanisms. To this aim, in-cell NMR is the ideal technique, as it is able to
analyse proteins at atomic resolution directly in living cells. The same
technique has been applied previously to observe changes in the in-
tracellular SOD1 folding, metallation and redox state as a consequence
of the physiological maturation and/or in response to external stimuli
[34–37].
2. Materials and methods
2.1. In-cell NMR
In-cell NMR experiments have been performed as previously de-
scribed [38] on living human embryonic kidney cells (HEK293T), under
three main experimental conditions: i) exposure to Zn2+ (added in the
culture at the time of transfection with SOD1); ii) exposure to Cd2+
(added in the culture 24 h after the transfection with SOD1); iii) ex-
posure to Zn2+and Cd2+ (both added in the culture at the aforemen-
tioned times). HEK293T cells were grown on uncoated 75 cm2 plastic
flasks at 37 °C in 5% CO2 atmosphere, and were maintained in Dul-
becco's Modified Eagle's medium (DMEM; high glucose, D6546, Sigma-
Aldrich, St. Louis, MO) supplemented with L-glutamine, antibiotics
(penicillin and streptomycin) and 10% foetal bovine serum (FBS)
(Gibco-Thermo Fisher Scientific, Waltham, MA). Cells were transiently
transfected with the pHLsec plasmid [39] encoding for human SOD1,
using polyethylenimine (PEI) in the ratio 1:1 (25 μg each), in 15N la-
belled media (BioExpress6000, Cambridge Isotope Laboratories, Inc.,
Tewksbury, MA), supplemented 2% FBS in the presence/absence of
Zn2+ as ZnSO4 10 μM. Under these conditions, ~150 μM SOD1 is ex-
pressed [38]. To decrease the expression levels of SOD1, the pHLsec
encoding SOD1 was mixed 1:1 with empty vector and transfected as
above, resulting in the expression of ~65 μM SOD1. 24 h after the
transfection, 10 μM of CdCl2 was added to the cell cultures; such con-
centration was chosen considering previous experiments performed on
Hep3B and N2A cells [32,40]. After 24 h of exposure to cadmium, the
cells were washed twice with PBS, trypsinised, spun at 500 g after
trypsin inactivation, resuspended once in PBS and spun down again at
500 g. Such procedure allows efficient removal of debris from dead cells
and of apoptotic cells, if present. Cell viability was assessed both before
and after NMR analysis by counting cells stained with trypan blue using
a Burker chamber. Cd2+ treatment caused a reduction of ~40% in the
final number of cells analysed by NMR, likely due to cell death/apop-
tosis. However, the fraction of cells treated with Cd2+ that was re-
covered and analysed by NMR had the same viability as the Cd2+-un-
treated cells (> 95% trypan blue-negative before the NMR
experiments, > 90% after the NMR experiments). For NMR analysis,
the recovered cells were collected and placed in a 3mm Shigemi NMR
tube. 1H WATERGATE (3-9-19) and 1H–15N SOFAST-HMQC NMR
spectra were acquired on living HEK293T cells and on lysates at a
950MHz Bruker (Billerica, MA) Avance III or at a 900MHz Bruker
Avance HD spectrometer both equipped with a TCI CryoProbe, at
308 K. The cell lysates were obtained by freeze-thaw lysis in phosphate
buffered saline (PBS) buffer, pH 7.4, followed by centrifugation at
14,000 rpm. For the [15N]-cysteine selective labelling of MTs, un-
transfected HEK293T cells were grown in homemade medium con-
taining [15N]-cysteine (Cambridge Isotope Laboratories, Inc.); NMR
spectra were acquired on the corresponding cell lysate at 298 K. All
NMR spectra were acquired and processed using Bruker Topspin soft-
ware. The uniformly-15N labelled in-cell NMR spectra were further
processed by subtracting a spectrum of cells transfected with empty
vector, acquired in the same experimental conditions, to eliminate the
signals arising from partial 15N labelling of other cellular components.
The intracellular oxidation state of E,Zn-SOD1 was determined from
the intensities of the signals arising from G10 and N53 Nδ1 in each
oxidation state in the 1H–15N NMR spectra. The amount of oxidised/
reduced E,Zn-SOD1 in each condition are reported as percentages over
total E,Zn-SOD1 calculated for two independent cell samples.
2.2. In vitro NMR
Recombinant SOD1 was demetallated as previously described [41]
by repeated dialyses against 10mM EDTA in 50mM acetic acid at pH
3.5. The buffer was then replaced with PBS, pH 7.4. Reduction of SOD1
disulfide bond was performed by incubating apo-SOD1SS with 50mM of
DTT for 40min at 37 °C. DTT was then removed in oxygen-free PBS
buffer.
In vitro NMR titration experiments were performed at 950MHz in
anaerobic conditions. E,Zn-SOD1SH was obtained by titrating 150 μM
apo-SOD1SH in PBS buffer, pH 7.4, with 1 equivalent of ZnCl2. Titration
with Cd2+ was performed by addition of increasing equivalents of
CdCl2 to a sample of 150 μM apo-SOD1SH. 1H WATERGATE (3-9-19)
and 1H–15N SOFAST-HMQC NMR spectra were acquired at 298 K after
each addition. Disulfide-oxidised E,Zn-SOD1 was prepared by titration
of apo-SOD1SS with one equivalent of Zn2+ monitored via NMR.
2.3. Real-time PCR
Gene expression analysis by Real-Time PCR has been performed
using the 2^(-ΔΔCT) comparative method of quantification [42]. Briefly,
total RNA (1 µg), extracted with TriReagent™ (Sigma-Aldrich) was re-
verse transcribed using iScript™ cDNA Synthesis Kit for RT-qPCR (Bio-
Rad Laboratories, Hercules, CA) according to the manufacturer's in-
structions. Human specific TaqMan Gene Expression Assays employed
for gene expression studies were purchased from Thermo Fisher Sci-
entific and listed in Table S1. The quantification of target gene mRNA
levels was performed employing TaqMan Universal Master Mix
(Thermo Fisher Scientific) with the automated ABI Prism 7500 Se-
quence Detector System (Thermo Fisher Scientific) as described pre-
viously [43]. Each measurement was carried out in triplicate, by ana-
lysing three independent cell samples. The quantification was
performed by simultaneous amplification of the target gene together
with the housekeeping (GAPDH) in order to normalise expression data.
Results were analysed by ABI Prism Sequence Detection Systems soft-
ware, version 1.7 (Applied Biosystems, Foster City, CA) and graphical
representations of data as mean ± SD of three independent experiment
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were obtained by GraphPad Prism 5.0 (GraphPad Software, San Diego,
CA).
3. Results
SOD1 overexpressed in human cells was analysed by in-cell NMR to
determine its metallation and redox state under different conditions, by
comparing the in-cell spectra with in vitro spectra of the protein in
known states. The metallation state was determined from the chemical
shift of the metal binding histidines in imino region of the 1H NMR
spectra. Under basal conditions (i.e. without addition of metals), a
fraction of overexpressed SOD1 binds the Zn2+ available in the growth
medium while the remaining fraction is in the apo state (apo-SOD1,
which gives no signals in the imino region), whereas addition of Zn2+
allows the complete Zn2+ binding to SOD1 with one Zn2+ per
monomer (E,Zn-SOD1), as previously reported [34] (Fig. 1a). Exposure
to Cd2+ for 24 h did not cause any Cd2+ binding to SOD1, as de-
termined by comparison with the in vitro NMR spectra. Indeed, the
histidine signals of intracellular SOD1 in the Cd2+-treated cells did not
change with respect to the untreated cells, matched those of apo-SOD1
metallated with Zn2+ in vitro and differed from those of apo-SOD1
metallated in vitro with increasing equivalents of Cd2+ per SOD1
monomer (Fig. 1b). Moreover, the titration performed in vitro denotes
that Cd2+ binds to SOD1 with lower affinity than Zn2+, as two
equivalents or more of Cd2+ are necessary to observe spectral changes,
suggesting that Cd2+ binding to apo-SOD1 or replacement of Zn2+ with
Cd2+ is unlikely to occur in the cells.
Instead, Cd2+ treatment caused the oxidation of a sizable fraction of
intracellular E-Zn,SOD1, i.e. the formation of an intramolecular dis-
ulfide bond between C57 and C146. In defect of Zn2+, the metal-free
protein is fully disulfide-reduced (apo-SOD1SH), while the form with
one Zn2+ bound per monomer is mostly in the reduced state (60–70%
E,Zn-SOD1SH over total E,Zn-SOD1, Fig. 2a). When Cd2+ was added to
the cells in defect of Zn2+, a sizable fraction (65–75%) of the zinc-
bound form was oxidised (E,Zn-SOD1SS), as revealed by the changes in
relative signal intensity in the 2D NMR spectra, while the apo form was
unaffected, i.e. it showed a NMR spectrum superimposable to that of the
untreated sample, indicating that it is in the disulfide-reduced state
(apo-SOD1SH) (Fig. 2a). The in-cell spectral changes induced by Cd2+
matched those observed in vitro between the reduced and oxidised
forms, i.e. E,Zn-SOD1SH and E,Zn-SOD1SS (Fig. 2b). Notably, the same
effect was observed in cells expressing SOD1 at lower levels, where
Cd2+ caused the oxidation of ~63% of E,Zn-SOD1 (Fig. S1).
The oxidation of SOD1 induced by Cd2+ was largely attenuated by
the addition of Zn2+. In the presence of excess Zn2+, intracellular E,Zn-
SOD1 was mostly found in the reduced state (80–90% E,Zn-SOD1SH), as
previously reported [34,36]. When both Zn2+and Cd2+ were supple-
mented, a smaller fraction (25–45%) of SOD1 was oxidised (E,Zn-
SODSS), while the rest of the protein remained reduced, as that ob-
served in the Zn2+-treated cell sample (Fig. 3). The considerably
smaller fraction of oxidised SOD1, compared to the sample supple-
mented only with Cd2+, suggested that a protective mechanism against
oxidative stress had been activated by supplementing Zn2+. We hy-
pothesised that such effect could have been exerted by MTs, considering
their protective role against cadmium, their involvement in zinc
homeostasis and their intracellular anti-oxidant action. Indeed, MTs are
well known to be overexpressed in cell lines and tissues as a con-
sequence of cadmium exposure [44,45]. Interestingly, analysing the
NMR data, several additional amide crosspeaks not originating from
any known state of SOD1 were observed in the 2D spectra of cells
treated with both Cd2+ and Zn2+ (Fig. S2). To further investigate the
origin of these signals, we performed additional in-cell NMR experi-
ments on cells not transfected with the plasmid encoding for SOD1, that
were grown in either uniform-15N or [15N]-cysteine labelled medium
and subsequently exposed to Cd2+. The unknown crosspeaks were also
present in the resulting NMR spectra (Fig. 4a), indicating that they did
not arise from SOD1 but from some other protein(s) upregulated upon
Cd2+ treatment. Strikingly, many signals (~20) were also present in the
[15N]-cysteine labelled sample (Fig. 4a and Fig. S3). Such a high ratio of
cysteine residues is typical of MTs. Therefore, MT overexpression could
explain the additional crosspeaks in Cd2+-treated cells, and the lower
amount of oxidised SOD1.
To confirm that MTs are overexpressed as a consequence of cad-
mium exposure and to identify which MT isoforms are upregulated the
most, we performed Real-Time PCR experiments on mRNA extracts
from cells either untreated or treated with Cd2+ and/or Zn2+. Real-
Time PCR analysis revealed that, indeed, expression of MTs was greatly
increased upon Cd2+ treatment in our experimental conditions (Fig. 4b
and Table S2). Specifically, in cells treated with Cd2+ MT-1X expression
was increased ~280-fold compared to the untreated cell sample, while
MT-2A expression was increased ~210-fold; MT-1F was also over-
expressed to a lesser extent (~20-fold). Considering that in the control
sample MT-1X and MT-2A are expressed respectively ~8 and ~60 times
more than MT-1A (taken as reference, Fig. 4c and Table S2), the levels
of MT-1X and MT-2A in Cd2+-treated cells reached up to ~2200 and
~12500 times the basal MT-1A levels, respectively, by far the highest
isoforms, thus suggesting that the observed NMR signals arise from
these isoforms. In cells treated with both Cd2+ and Zn2+, an increase in
the levels of MT-1X and MT-2A was observed (respectively, ~300- and
~260-fold), while in cells treated only with Zn2+ a much lower MT
overexpression was observed (Fig. 4d,e and Table S3).
Real-Time PCR MTs expression analysis was also performed on cells
overexpressing SOD1 as it occurs in the in-cell NMR samples upon
supplementation of Cd2+ and/or Zn2+. Interestingly, in cells expressing
Fig. 1. Intracellular SOD1 binds Zn2+, not Cd2+. Imino region of (a) in-cell
1H NMR spectra of cells expressing [U-15N] labelled SOD1 and treated with
different metals (red); (b) in vitro 1H NMR spectra of disulfide-reduced apo-
SOD1 (120 μM) alone (blue), titrated with 1 equivalent per monomer of Zn2+
(blue) and titrated with 2, 3 and 4 equivalents per monomer of Cd2+ (black).
The histidine signals corresponding to the E,Zn-SOD1 form are shown with
dashed lines and labelled. Signals likely arising from the non-native Zn,Zn-
SOD1 form are labelled with asterisks. Spectral regions containing signals
arising from Cd2+ binding to SOD1 are shown in grey.
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SOD1 a different behaviour was observed in defect of Zn2+ versus ex-
cess of Zn2+, upon Cd2+ treatment. In cells expressing SOD1 in defect
of Zn2+, Cd2+ treatment still induced the expression of MT-1X and MT-
2A, but at significantly lower levels (~90- and ~50-fold, respectively,
compared to basal levels) than in untransfected cells, while excess Zn2+
in SOD1-expressing cells significantly restored the Cd2+-induced ex-
pression of MT-1X and MT-2A to levels (~380- and ~180-fold, re-
spectively) similar to those reached in untransfected cells (Fig. 4e and
Table S3). These data are consistent with the fact that MTs were not
detected by NMR in cells expressing SOD1 in defect of Zn2+ (Fig. S4).
Upregulation of MTs was much lower in cells (both untransfected
and transfected with SOD1) treated with Zn2+ in excess but not ex-
posed to Cd2+ (Fig. 4d). Taken together, these data indicate that cad-
mium is the main trigger of MT overexpression and that SOD1 and zinc
supplementation can modulate Cd2+-induced MT overexpression in
opposite ways.
4. Discussion
In-cell NMR allows a direct assessment of the intracellular state of
SOD1 upon Cd2+ treatment, and therefore can provide a close-to-
physiological picture of the effect of cadmium exposure on SOD1 in
human cells. Previous in vitro NMR studies demonstrated that Cd2+ is
able to bind to the zinc and copper sites of SOD1 [30], while studies on
animal models showed that Cd2+ affects the superoxide dismutase ac-
tivity in several tissues [31–33]. We therefore sought to determine
whether direct binding of Cd2+ to SOD1 can occur in living cells. By in-
cell NMR, we did not observe any direct Cd2+ binding to SOD1, as
SOD1 was present only with one Zn2+ bound per monomer or in the
apo state. Indeed, the chemical shifts of the signals arising from the
metal-coordinating histidines observed in the Cd2+-treated cells were
identical to those of E,Zn-SOD1 in-cell and in vitro, and differed from
those observed when apo-SOD1 was titrated in vitro with increasing
equivalents of Cd2+ (Fig. 1). Moreover, different species were si-
multaneously present during the titration and residual apo-SOD1 was
Fig. 2. Cd2+ induces intracellular SOD1 oxidation. (a) Overlay of in-cell 1H–15N NMR spectra acquired on cells expressing [U-15N] labelled SOD1 in defect of
Zn2+ either untreated (black) or treated (red) with Cd2+; (d) overlay of in vitro 1H–15N NMR spectra acquired on disulfide-reduced E,Zn-SOD1 (blue) and dis-
ulfide—oxidised E,Zn-SOD1 (orange); (b, c, e, f) enlarged areas of the same spectra (dotted rectangles in a, c). Representative signals affected by the formation of the
C57-C146 disulfide bond are labelled.
Fig. 3. Excess of Zn2+ prevents Cd2+-induced SOD1 oxidation. (a) Overlay
of in-cell 1H–15N NMR spectra acquired on cells expressing [U-15N] labelled
SOD1 in excess of Zn2+ either untreated (black) or treated (magenta) with
Cd2+; (b, c) enlarged areas of the same spectra (dotted rectangles in a).
Representative signals affected by the formation of the C57-C146 disulfide bond
are labelled.
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still present after up to two equivalents of Cd2+. This behaviour is
consistent with Cd2+ binding with low selectivity to either the zinc or
the copper site of SOD1. At a protein concentration of 120 µM, the Kd
can be estimated in the order of ~10-4 M, strikingly higher than that of
Zn2+ binding to its native site (Kd = 4.2×10-14 M [46]), indicating
that Cd2+ binding to intracellular SOD1 in place of Zn2+ would not be
thermodynamically favoured.
Despite the lack of direct binding to intracellular SOD1, a clear ef-
fect of Cd2+ treatment was the oxidation of SOD1 cysteines, i.e. the
formation of the intrasubunit disulfide bond between C57 and C146.
This outcome is likely a consequence of an intracellular redox un-
balance caused by Cd2+. The disulfide bond formation is required for
the correct maturation of SOD1, as it stabilises the protein structure and
is essential for its activity [47,48]. Moreover, the ability of an exo-
genous redox-reactive compound to stabilise SOD1 by promoting dis-
ulfide oxidation has also been reported [37]. While cysteine oxidation
contributes to stabilise the protein, it could interfere with the native
maturation pathway, as SOD1 needs to interact with its partner copper
chaperone for SOD1 (CCS) in order to bind copper [49,50]. SOD1 in-
teracts with CCS more efficiently in the reduced state [51,52]. Upon
interaction, CCS delivers copper to SOD1 and catalyses its oxidation,
thus producing mature SOD1 [53,54]. The premature oxidation of
SOD1 could therefore prevent the interaction with CCS and impair
copper delivery, as shown previously in yeast [55] and with human
SOD1 in vitro [54]. Such effect would be consistent with the decrease of
superoxide dismutase activity reported in vivo [13,31]. Cd2+-mediated
SOD1 oxidation did not occur in the presence of excess Zn2+, thus
suggesting that Zn2+ could modulate the extent of the effect of Cd2+.
Notably, this mechanism cannot involve mature Cu,Zn-SOD1, as the
disulfide bond is already formed and Cd2+ would not be able to replace
either zinc or copper, which is bound to SOD1 with even higher affinity.
Furthermore, we observed that Cd2+ treatment strongly induced the
overexpression of the metallothionein isoforms MT-1X and MT-2A.
Interestingly, while MT overexpression is a well known consequence of
Cd2+ exposure [44,45], MT-1X and MT-2A reached such high levels in
our experimental conditions that they could be observed by in-cell
NMR. Based on the estimated detection limit of the technique of ~5 µM
for small folded proteins and on previous in-cell NMR analyses of other
proteins [36], the concentration of MTs in the NMR tube was estimated
around 5–10 µM. While in principle the high spectral resolution should
allow separating the signals of MT-1X and MT-2A, only one set of re-
sonances could be identified due to the low signal-to-noise ratio and
likely because most signals have the same chemical shift due to the high
structural similarity of the two isoforms, which have an overall se-
quence identity> 90% and share a central stretch of 38 identical re-
sidues. Strong MT induction required the presence of Cd2+, and was
also observed in HEK293T not transfected with the SOD1 gene, where
Zn2+ supplementation further potentiated the MT induction. Interest-
ingly, SOD1 overexpression negatively modulated the level of Cd2+-
mediated MT induction, and indeed in such experimental conditions,
where SOD1 was partially oxidised upon Cd2+ treatment, MT-1X/MT-
2A did not reach sufficiently high levels to be detected in the NMR
spectrum. Conversely, supplementation of both Cd2+ and Zn2+ to cells
overexpressing SOD1, i.e. in the experimental conditions where SOD1
was mostly reduced, Cd2+-mediated MT induction was restored, and
high MT-1X/MT-2A levels were observed in the NMR spectrum.
Such interplay between Zn2+, MT expression and SOD1 oxidation
can be rationalised by considering the role of MTs in the cellular
homeostasis of zinc. Zinc is an essential metal for the correct func-
tionality and health of the cell. However, due to its high affinity for
biological molecules, its intracellular availability has to be regulated to
avoid uncontrolled binding to non-native acceptors. MTs, along with
the other high affinity zinc-binding proteins, contribute to buffering the
intracellular Zn2+ concentration [18]. Furthermore, both MTs and
Zn2+ are involved in the cellular redox homeostasis [18,56]. When
intracellular Zn2+ increases, it binds to the metal regulatory
Fig. 4. Cd2+ treatment induces MT overexpression to NMR-detectable levels. (a) Overlay of 1H–15N NMR spectra acquired on untransfected cells treated with
Cd2+ either [U-15N] labelled (black) or [15N-cysteine] labelled (red); (b–e) Real-Time PCR analysis: (b) expression of different MT isoforms in Cd2+-treated un-
transfected cells, relative to basal (i.e. untransfected cells not treated with Cd2+). Significant values are marked with asterisks (Student's t-test, ** = P < 0.01; *** =
P < 0.001). (c) Basal expression of different MT isoforms relative to that of MT1A. Significant values are marked with asterisks (1-way ANOVA followed by
Bonferroni post-hoc test, *** = P < 0.001). (d) Expression of MT1X and MT2A in cells not treated with Cd2+, overexpressing SOD1 in defect/excess of Zn2+,
relative to basal. (e) Expression of MT1X and MT2A in cells treated with Cd2+, overexpressing SOD1 in defect/excess of Zn2+, relative to basal. Significant
differences are marked with asterisks (2-way ANOVA followed by Bonferroni post-hoc test, * = P < 0.05, ** = P < 0.01, *** = P < 0.001). Ctrl: untransfected,
untreated cells; +Zn2+: cells treated with excess Zn2+; +Cd2+: cells treated with Cd2+; o/e SOD1: cells overexpressing SOD1.
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transcription factor 1 (MTF-1), activating it and triggering the tran-
scription of more MTs [21]. Consequently, when Cd2+ is added to the
cells it displaces Zn2+ from MTs and other proteins, releasing it in the
cytoplasm and causing it to activate MTF-1, inducing MTs over-
expression (Fig. 5, left). In turn, overexpressed MTs protect the cells by
directly binding Cd2+ and possibly by exerting other antioxidant
functions [18]. When Cd2+ is added to cells overexpressing SOD1, the
released Zn2+ is immediately sequestered by SOD1, which has a much
higher affinity than MTF-1 and MTs, preventing the activation of MTF-1
and decreasing MTs overexpression as a consequence (Fig. 5, centre).
Instead, when both Zn2+ and Cd2+ are supplemented, overexpressed
SOD1 is fully metallated by the excess of Zn2+, so that the amount
released by the MTs can still bind to MTF-1, restoring the high induc-
tion of MTs to NMR-detectable levels (Fig. 5, right). Finally, the dif-
ferent oxidation state of SOD1 observed when supplementing both
Zn2+ and Cd2+ can be explained with the fact that in cells with higher
levels of MTs the cellular redox balance is partially restored, preventing
the premature oxidation of SOD1.
5. Conclusions
In this work, the effect of cadmium treatment on the metallation
and redox state of SOD1 was investigated directly in human cells by in-
cell NMR. Our study revealed an interesting relationship between the
SOD1 redox state, the availability of Zn2+ and the Cd2+-induced
overexpression of MTs. While Cd2+ itself does not bind SOD1 in place
of Zn2+, it is able to induce the premature formation of SOD1 in-
tramolecular disulfide bond, interfering with its correct maturation
pathway. Furthermore, Cd2+ alters the cellular zinc homeostasis
causing a strong induction of MTs. Such induction is negatively
modulated by the overexpression of SOD1 itself, likely because the in-
creased SOD1 levels interfere with the activation of the MT transcrip-
tion factor MTF-1. While in our experiments the levels of SOD1 are
artificially increased, our findings suggest that in cells with en-
dogenously high levels of SOD1 (~40–100 µM), such as motor neurons
and erythrocytes [57,58], under certain conditions, SOD1 itself could
sensitise the cells to Cd2+ toxicity, by sequestering the Zn2+ displaced
by Cd2+, inhibiting the cellular response against Cd2+ and further al-
tering the cellular redox balance.
Finally, as an interesting remark from the methodological point of
view, we report that the strong induction of MTs resulted in the ob-
servation of NMR signals from MT-1X/MT-2A. To the best of our
knowledge, this is the first time that signals from a protein synthesised
by genomic DNA, i.e. not delivered into the cells nor ectopically
expressed, could be detected by solution NMR in human cells.
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